New and Evolving Therapeutic Targets in Lung Cancer: Expert Guidance in Incorporating Biomarker Testing to Deliver Precision Therapy

Download All
Gain expert insights on how to test for new and emerging molecular targets and incorporate targeted agents into the care of your patients with lung cancer with downloadable slides and on-demand Webcasts from live meetings, biomarker summary handouts, and a decision support tool providing the latest individualized guidance on precision therapy for NSCLC.

Downloadable Resource

Download this PDF resource for clinical insights on new and established clinical biomarkers guiding NSCLC management, including best testing practices.

Released: June 19, 2020
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from

For further information concerning Lilly grant funding, visit

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings